Loading clinical trials...
Loading clinical trials...
IMFINZI® Injection 120 mg, 500 mg Specific-Clinical Experience Investigation in Patients With Extensive Stage Small Cell Lung Cancer
Conditions
Locations
18
Japan
Research Site
Chiba, Japan
Research Site
Fukuoka, Japan
Research Site
Gunma, Japan
Research Site
Hokkaido, Japan
Research Site
Hyōgo, Japan
Research Site
Kanagawa, Japan
Start Date
April 22, 2021
Primary Completion Date
July 25, 2023
Completion Date
July 25, 2023
Last Updated
July 24, 2024
NCT03212404
NCT07476287
NCT00263731
NCT00826644
NCT03092739
NCT02366741
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions